Furthermore, based on cancer tissue staining intensity, we categorized 85 patients with available clinical data into high ERCC6L (n = 61) and low ERCC6L (n = 24) groups, and subsequently conducted statistical comparisons of various clinicopathological features between the two groups (Table 3). Here, ERCC6L is linked to cancer.